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Abstract.  We have localized several major extracellu- 
lar matrix protein receptors in the specific granules of 
human polymorphonuclear (PMN) and monocytic leu- 
kocytes using double label immunoelectron microscopy 
(IEM) with ultrathin frozen sections and colloidal-gold 
conjugates. Rabbit antibodies to 67-kD human laminin 
receptor (LNR) were located on the inner surface of 
the specific granule membrane and within its internal 
matrix. LNR antigens co-distributed with lactoferrin, a 
marker of specific granules, but did not co-localize 
with elastase in azurophilic granules of PMNs.  Fur- 
ther, CDllb/CD18  (leukocyte receptor for C3bi, 
fibrinogen, endothelial cells, and endotoxin), mam- 
malian fibronectin receptor (FNR), and vitronectin 
receptor (VNR) antigens were also co-localized with 
LNR in PMN specific granules. A  similar type of 
granule was found in monocytes which stained for LNR, 
FNR,  VNR, CDI8, and lysozyme. Activation of 
PMNs with either PMA, f-met-leu-phe (fMLP), tumor 
necrosis factor (TNF), or monocytic leukocytes with 
lipopolysaccharide (LPS), induced fusion of specific 
granules with the cell membrane and expression of 
both LNR and CD18 antigens on the outer cell sur- 
face. Further, stimulation led to augmented PMN 
adhesion on LN substrata,  and six- to eightfold in- 
creases in specific binding of soluble LN that was in- 
hibited by LNR antibody. These results indicate that 
four types of extracellular matrix receptors are located 
in leukocyte specific granules, and suggest that up- 
regulation of these receptors during inflammation may 
mediate leukocyte adhesion and extravasation. We have 
thus termed leukocyte specific granules adhesomes. 
XTRAVASATION of  polymorphonuclear  leukocytes 
(PMNs) m  and monocytes and their entrance into in- 
flammatory tissue sites requires that they adhere to 
and penetrate the capillary endothelium, the basement mem- 
brane, and the stromal connective tissue (14, 42, 60). The 
hematogenous spread of metastatic cells occurs via a similar 
mechanism (3,  32).  Certain cell surface receptors for ex- 
tracellular l  igands play central roles in these adhesion-de- 
pendent processes, and the molecular mechanisms underly- 
ing these interactions are being elucidated (27, 36, 48, 49). 
The dominant adhesive ligand of basement membranes is 
laminin (LN) (36), whereas fibronectin (FN) and vitronectin 
(VN) are attachment ligands of the connective tissue stroma 
(23, 48, 49);  other important adhesive molecules such as 
ICAM-1 and ELAM-1 are expressed on the endothelial cell 
surface (8,  9,  13,  35).  Several types of laminin  receptors 
(LNRs) have been described. A LNR with a molecular mass 
of 67 kD has been identified in neoplastic cells, PMNs, mac- 
1. Abbreviations  used in this paper: ECMR, extracellular matrix receptor; 
fMLP,  f-met-leu-phe;  FN,  fibronectin; FNR,  fibronectin receptor; IEM, 
immunoeleetron microscopy; LN, laminin; LNR, laminin receptor; LPS, 
lipopolysaccharide;  PMN, polymorphonuclear; TNF,  tumor necrosis fac- 
tor; VN, vitronectin; VNR, vitronectin receptor. 
rophages, and myocytes (25, 31, 37, 46, 60, 61, 68, 78). This 
receptor consists of a single polypeptide exhibiting saturable 
LN binding of moderate affinity (Kd '~nM) (2, 25, 46). Ad- 
ditional  LN-binding  proteins  include 180 kD and 110-120 
kD species found in neural and epithelial cells (30, 58), and 
several recently described integrins with LN-binding activ- 
ity (20, 24, 28, 59, 63). Of these LNRs, 67-kD LNR appears 
to be the dominant laminin binding  protein in PMNs and 
macrophages (25, 37, 78). Surface expression of 67-kD LNR 
in PMNs is elevated by inflammatory agonists such as PMA 
or f-met-leu-phe (fMLP) (78); high levels of 67-kD LNR are 
also expressed in oncogenically transformed cells (3, 21, 68, 
79), suggesting that increased adhesion to basement mem- 
branes occurs during diapedesis. 
Receptors for FN and VN are integrins;  a superfamily of 
heterodimeric cell surface receptors composed of closely 
similar or identical beta subunits and alpha subunits that are 
apparently  unique for each receptor (27, 49).  Integrins  in- 
clude a subgroup of receptors which mediate leukocyte ag- 
gregation and adhesion to vascular endothelial cells: Mac-l, 
LFA-1, and p150,95 (1, 22, 29, 51, 72). Their specific alpha 
subunits have been defined as CDlla (LFAol), CDllb (Mac- 
1),  and  CDllc  (p150,95),  and each receptor contains  an 
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while ligands for Mac-1 include C3bi, fibrinogen, and endo- 
toxin (35,  75-77).  As with LNR, inflammatory stimuli in- 
duce rapid expression of Mac-1 and p150,95 on the granulo- 
cyte surface (22,  38, 62, 64). 
Although the molecular mechanisms of leukocyte interac- 
tion with endothelial cells, basement membranes, and stro- 
mal connective tissue arc being elucidated, little high resolu- 
tion structural data is available on the subcellular distribution 
of relevant adhesive receptors. Further, the effects of several 
different physiological inflammatory mediators such as fMLP, 
tumor necrosis factor (TNF), and bacterial lipopolysaccha- 
ride (LPS) upon the expression and/or subcellular redistri- 
bution of these receptors has not been examined extensively 
at the ultrastructural level. In this study, dual-label immuno- 
electron microscopy (IEM) was used to determine the distri- 
bution of 67-kD LNR, CD18, fibronectin receptor (FNR), 
and vitronectin receptor (VNR)  relative to known subeellu- 
lar markers in resting and activated PMNs and monocytes. 
We report that all four adhesion receptors are located in the 
leukocyte specific granule which becomes translocated to the 
cell surface after activation; specific granules have thus been 
termed "adhesomes: 
Materials and Methods 
Preparation and Activation of  Human Leukocytes 
Peripheral blood was obtained from normal human volunteers and PMNs 
isolated  on discontinuous  Ficoll-Hypaque  density  gradients  (Pharmacia 
Fine Chemicals, Piscataway,  NJ). The cells were 98% pure (contaminated 
with eosinophils detected by electron microscopy) and 99% viable (deter- 
mined by lactate dahydrogenase liberation into the medium  [26]).  After 
washing with ice-cold calcium/magnesium-free Hanks' balanced salt solu- 
tion (HBSS) buffered with 20 mM Hepes (pH 7.2), PMNs were activated 
by various agents. For fMLE  PMNs were suspended at 2  x  106 cells/ml 
and preincubated with 5/~g/mi cytochalasin D in calcium/magnesium con- 
raining HBSS for 10 min followed by washing and treatment with  1 /zM 
fMLP for 20 min at 37°C. At this point the cells were either washed with 
HBSS for fixation (see below), or with binding buffer (HBSS containing 2 
mM calcium [magnesium-free] and 2% human serum albumin [New York 
Blood Center, New York]) for LN binding experiments. Similarly, PMNs 
were activated with 50 or 500 ng/ml PMA (0.1-1.3/~M) or with ionophore 
A23187 (1.0 p.M)  for 20 rain. A  recombinant form of human TNF alpha 
(frNF)  (Genzyme Corp.,  Boston,  MA) was used to activate either sus- 
pended PMNs, or cells plated (1  x  107 PMNs per dish) into 90-mm-diam 
tissue culture dishes (No.  25020;  Coming  Glass Works,  Coming,  NY) 
coated with purified murine LN for 1 h. The degree of PMN activation was 
determined by measuring the amount of myeloperoxidase or vitamin Bi2 
binding activity liberated, respectively, from azurophilic or specific gran- 
ules as previously described (34, 47), and possible cell lysis was quantified 
by measuring release of lactate dehydrogenase after stimulation (26). Mono- 
cytes were isolated from leukophoresed human peripheral blood using Lym- 
phocyte Separation Medium (Organon Teknika Corp.,  Durham,  NC) and 
purified by elutriation (70); monocyte-containing fractions were identified 
by immunofluoresccnt staining with Leu M-3 antibody (Becton-Dickinson, 
Mountain View, CA) and analysis by flow cytometry. Adherent cultures of 
purified monocytes were established in medium containing 1% FBS and ac- 
tivated with 1 #g/ml LPS (E.  coli, strain 055.B5P; Sigma Chemical Co., 
St. Louis,  MO) for 20 h as previously described (55). 
Proteins 
LN was purified from Englebreth-Holm-Swarm sarcomas propagated sub- 
cutaneously in germ-free C57J/B6 mice by salt extraction and gel filtration 
on Sepharose CI-6B with 2 M GnHCI as recently described (43). Additional 
LN  samples  and  original  Englebreth-Holm-Swarm  tumor-beating  mice 
were gifts of Drs. Hynda Kleinman and George Martin (National Institute 
of Dental Research, National Institutes of Health, Bcthesda, MD). The LN 
consisted of intact 400- and 200-kD alpha and beta chains and was essen- 
tially free of nidogen; purity was estimated to be >98% on silver-stained 
SDS-PAGE under reducing conditions. For soluble LN-binding assays, this 
ligand was centrifuged at 13,000 g for 15 rain to remove putative aggregates, 
and  radioiodinated  with Bolton-Hunter  reagent  (New  England  Nuclear, 
Boston, MA) according to the manufacturer's directions. Uncoupled reagent 
was separated from iodina~d LN using a TSK 400 HPLC column. Specific 
activity of iodinated iigand ranged from 1 to 3 #Ci/p.g, and 98-99% of the 
radioactivity was TCA precipitable. The radioligand was electrophoresed 
and autoradiographed to assess its purity and integrity. Only two heavily la- 
beled major bands representing the alpha and beta chains of LN were ob- 
served. 67-kD LNR was purified from human PMN specific granules (12) 
on a LN-Sepharose affinity column as previously described (30, 68). FN 
was isolated from outdated human plasma (New York Blood Center, New 
York) using gelatin-Sepharose chromatography. 
Antibodies 
The following antibodies used for IEM at the indicated concentrations were 
kindly provided by the investigators listed: affinity-purified rabbit IgG (10 
/~g/ml) to a LNR fusion protein (fp9) expressing the 295 COOH-terminal 
amino acid sequence of human 67-kD LNR  (52) and the corresponding 
preimmune serum (Drs.  B. Segui-Real and Y.  Yamada, National Institute 
of Dental Research, National Institutes of Health, Bethesda, MD); rabbit 
antiserum to purified native human 67-kD LNR (1:200) (69) (Dr.  Lance 
Liotta, National Cancer Institute, National Institutes of Health, Bethesda, 
MD); murine monoclonal IgGs 60.3 and 60.1  (85/zg/ml) recognizing the 
CDI8 and CDllb components, respectively, of the Mac-I receptor (5, 66) 
(Dr. John Harlan, Harbor View Medical Center, Seattle, WA); affinity-puri- 
fied rabbit IgGs against the alphas subunit of human FNR and the alphav 
chain of VNR, as well as purified placental FNR and VNR (56) (Drs. James 
Gailit and Erkki Ruoslahti, La Jolla Cancer Research Center, La Jolla, CA); 
and rabbit antiserum (anti-GE No. 610019) to purified human sputum elastase 
(1:30) (Dr. Joan Dawes, University of Edinburgh, Edinburgh, Scotland, UK). 
Purified rabbit IgGs to human lacto ferrin and to human lysozyme were pur- 
chased from Accurate Chemical & Scientific Corp. (Westbury,  NY) and used 
at a 1:30 dilution. These antibodies were detected indirectly with secondary 
antibodies or protein A conjugated to colloidal gold: affinity-purified goat 
anti-rabbit IgG linked to 5-nm gold particles (garGS), affinity-purified goat 
anti-mouse IgG attached to 10-nm gold (gamGl0), and pA linked to either 
5- or 10-nm gold (pAGS; pAGl0) (Janssen Life Science Products, Piscata- 
way, N J). 
lramunoelectron Microscopy 
Resting or activated leukocytes in HBSS with 0.1% HSA and 20 mM Hepes 
(pH 7.2) were fixed for IEM with 3.5% paraformaldehyde, 0.1% glutaralde- 
hyde, 0.1 M Na-cacodylate (pH 7.2), and 0.1 M sucrose for 30 rain at 23°C. 
Since  leukocytes  (particularly  PMNs)  contain  several  potent  proteases 
which disrupt cellular ultrastructure and antigenicity during preservation, 
the following inhibitors were dissolved in our fixative: 1 mM EDTA, 4 mM 
Na-tetrathionate, 30 #M pepstatin, and 4 mM PMSE These protease inhibi- 
tors markedly  improved the ultrastructural preservation of our leukocyte 
preparations. To allow access of our immunoprobes to intracellular com- 
partments, pellets of fixed leukocytes were cut into ultrathin ('~80 nm) fro- 
zen sections at -95°C as previously described (55). Briefly, fixed cells were 
embedded in 7% acrylamide and the blocks infiltrated with 2.3 M sucrose 
in 0.1 M phosphate buffer (pH 7.2). To improve the cryopreservation, speci- 
mens were injected mechanically at a velocity of 3 m/see into various cryo- 
gens and rapidly frozen at their melting point with a  KF-80 immersion 
cyrofixation apparatus (Reichert-Jung Optische Werke,  Vienna, Austria): 
Freon 22 (-155°C), ethane (-171°C), or propane (-190°C).  This method 
is much more reproducible than manual freezing techniques (57), and we 
observed that either ethane or propane produced the most consistent cryo- 
preservation. Reduction of free aldehydes using NaBl-h, adsorption with 
a  clarified solution of nonfat milk,  and indirect staining of intraceUular 
antigens exposed on the surfaces of thin cryosections mounted on formvar- 
coated nickel grids were performed as previously described (55). For con- 
trois, the grids were incubated with purified Englebreth-Holm-Swarm sar- 
coma LN or human plasma FN (100 p.g/ml in 0.1 M  NaHCO3 [pH 8.5]), 
before labeling with LNR antibodies.  Alternatively, extracellular matrix 
receptor antibodies were pretreated with saturating concentrations (ll0-170 
/~g/ml) of relevant or irrelevant purified receptor, centrifuged at 15,000 g, 
and the supernatants used for IEM staining. Further controls were preim- 
mune or nonimmune rabbit or mouse IgG. The following protocols were 
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body/gamGl0 (alternatively,  primary and secondary antibodies were ap- 
plied as clarified mixtures); (b) rabbit antibody/pAG5/pA (50 t~g/ml; Sigma 
Chemical Co.)/mouse or rabbit antibody/pAG10. Between each step the sec- 
tions were washed seven times with 0.1 M Tris-HCl  (pH 7.8). After immu- 
nostaining,  the labeled leukocyte sections were fixed with 2% glutaraide- 
hyde and negatively stained with 1% phosphotungstate  (pH 7.0). Specimens 
were analyzed and photographed in a JEOL 100CX II transmission electron 
microscope operating at 80 kV. 
Results 
Immunoblotting of  Human PMNs 
Immunoblotting experiments were conducted to determine 
the PMN proteins recognized by the 67-kD LNR antibodies 
used  in  this  study (Fig. 1).  Whole-cell  extracts,  isolated 
specific granules (lane 2), and affinity-purified  LNR (lane 3) 
were immunoblotted with antibodies to fp9 (an E. coli fusion 
protein expressing the COOH-termina1295-amino acid resi- 
dues of human 67-kD LNR [52]),  to purified native human 
67-kD  LNR (69), or to lactoferrin. With LNR/fp9 antibod- 
ies, specific granules (lane 5) and isolated LNR (lane 6) ex- 
hibited a single reactive 67-kD protein; no staining of a 32- 
kD band (52)  was observed (lanes 5 and 6).  LNR/fp9 IgG 
did not recognize human serum albumin (lane 4).  Similar 
results were obtained with extracts of unfractionated PMNs 
and antibodies to purified native 67-kD  LNR (not shown). 
Lactoferrin antibodies labeled a  77-kD  protein of specific 
granules (lane 7). 
Distribution of  LNR in Resting Human PMNs 
Antibodies to native 67-kD  LNR or to LNR/fp9 were both 
localized in the electron lucent granules of unstimulated hu- 
man PMNs (Fig. 2, A and B). (Because LNR/fp9 IgGs have 
little likelihood of containing antibodies to putative mam- 
malian contaminants, this reagent was used to localize 67-kD 
LNR in most experiments.) LNR antigens were situated on 
the inner surface of the lucent granule membrane (Fig. 2 B, 
arrowheads) and within its internal matrix; electron dense 
granules and the plasmalemma were not stained (Fig. 2 B). 
However, sparse LNR/fp9 staining was detected on the plas- 
ma membranes of PMNs fixed with a formaldehyde solution 
lacking glutaraldehyde (not shown). LNR/fp9 labeling of lu- 
cent granules was eliminated by preincubating PMN cryo- 
sections with purified LN before immunostaining (Fig. 2 C); 
similar treatment with FN did not inhibit LNR staining (Fig. 
2 D). This demonstrates the immunospecificity of our stain- 
ing since LN presumably binds LNR sites on the cryosection 
surface thus preventing access to LNR antibodies. Similarly, 
antibodies to CD18 and CDllb (the beta and alpha subunits 
of the Mac-1 complex) were localized in PMN lucent gran- 
ules (Fig. 2, E and F), and 67-kD LNR antigens were also 
detected in the electron lucent granules of human eosinophils 
(Fig. 2  G). 
LNR and CDI8 Antigens Are Co-localized within 
PMN-specific Granules 
Double-label  IEM  was performed to determine if 67-kD 
LNR and CD18 antigens were localized in the same lucent 
granule,  and  whether  they  co-localized  with  established 
markers of PMN-specific or azurophilic granules. With col- 
Figure 1. Immunoblotting  of 67-kD LNR fusion protein (fp9) IgG 
on isolated PMN specific granules and purified LNR. Lanes 1-3 
are silver-stained PAGE gels of molecular mass markers ×10  -3 
(lane 1), PMN specific granules from the 1.07-1.09 density range 
of a Percoll gradient (lane 2), and purified LNR extracted from 
specific granules and isolated by LN-Sepharose chromatography 
(lane 3). Lanes 4-6 are autoradiograms  of immunoblotted  samples 
stained with LNR fp9 IgG followed by ~25I-protein A.  Lane 4, 
purified human serum albumin; lane 5, specific granule fraction 
shown in lane 2; lane 6, purified LNR depicted in lane 3. Lane 7 
is the specific granule fraction (lane 2) immunoblotted with lacto 
ferrin antibodies. 
loidal gold conjugates of either species specific secondary 
antibodies or protein A (5 nm for LNR; 10 nm for CD18), 
67 kD LNR and CD18 epitopes were co-distributed in the 
lucent granules of resting human PMNs (Fig. 3 A). Both an- 
tigens were especially concentrated on the inner surface of 
the granule membrane (Fig.  3  B),  but were also present 
within its central matrix.  Further,  LNR co-localized with 
lactoferrin antigens (Fig. 3, C and D) and did not co-distrib- 
ute with elastase epitopes in the dense azurophilic granules 
(Fig. 3, E and F), thus establishing that 67-kD  LNR is lo- 
cated within the specific granules of human PMNs. 
Immunolocalization of  LNR and CD18 in Stimulated 
Human PMNs 
Parameters  for optimal stimulation of PMNs  were deter- 
mined with in vitro assays for liberation of myeloperoxidase 
(from azurophilic granules) and vitamin Bt2 binding protein 
(from specific granules)  into the culture medium;  PMNs 
were pelleted immediately after stimulation and fixed for 
IEM  (Table  I).  Treatment of suspended PMNs  with 500 
ng/ml PMA, or with 5 #g/ml cytochalasin  D and 1 #M fMLP 
stimulated significant secretion of the specific granule mark- 
er. For cells plated on a LN-c0ated substratum, 10 nM rTNF 
alpha produced a similar effect. Activation with these stimuli 
produced very little PMN lysis as evidenced by the low levels 
of lactate dehydrogenase release.  Since  67-kD  LNR  and 
CD18 epitopes were co-localized in specific granules of rest- 
ing PMNs, we studied the subcellular distribution of the lat- 
ter receptors after stimulation with these agonists (Fig. 4). 
PMNs exhibited fusion of LNR-containing specific granules 
with the plasmalemma (Fig. 4 A), and moderate amounts of 
67-kD LNR antigens were observed on the outer cell surface 
(Fig. 4 C) after activation with rTNF alpha. Similarly, stim- 
ulation with PMA, or cytoehalasin D and fMLP (not shown) 
induced expression of LNR and the contents of specific gran- 
ules at the PMN surface (Fig. 4 B). LNR epitopes were also 
Singer et al. PMN and Monocyte Specific Granules Containing ECM Receptors  3171 Figure 2.  IEM localization of 67-kD LNR, Mac-I beta (CD18), and Mac-1  alpha (CDIlb) subunits on ultrathin cryosections of resting 
human PMNs and eosinophils (Eos) prepared as described in Materials and Methods. Sections were stained with the indicated primary 
antibodies followed by garG10 (A), pAG5 (B, C, D, F, and G) or gamGl0 (E). (,4) Antibodies to intact native LNR were located in electron 
lucent granules (arrowhead) but not in dense granules (arrow)  of the human PMN.  (B) LNR/fp9 antigens (affinity-purified IgG) were 
also found within lucent granules and were localized on the inner surface of its membrane (arrowheads) and within its internal matrix; 
the plasmalemma (arrows) was unstained. (C) Labeling of LNR/fp9 antigens in PMN lucent granules (arrowheads) was prevented by pre- 
incubating the sections with purified LN, but not with FN (D). A similar distribution of CD18 (E) and CDllb (F) antigens was found 
in PMNs. Likewise, eosinophils had lucent granules (arrowhead)  with LNR/fp9 antigens (G). Bars: (A-D, F,, and G) 200 urn; (E) 100 nm. 
Figure 3. Double-label IEM staining of LNR/fp9 and CDI8 antigens relative to each other and to known markers of specific granules (lacto 
ferrin) and azurophilic granules (elastase) on ultrathin cryosections of unactivated human PMNs. Samples were prepared and immuno- 
stained using protocol b described in Materials and Methods. A and 8  were double labeled for LNR/fp9 (GS) and CD18  (G10) antigens. 
(A) Electron lucent granules (arrowheads)  were positive for CD18 and LNR/fp9, whereas dense granules (arrow) were unstained. (B) Both 
LNR and CD18 were localized to the inner membrane surface (arrowheads)  and internal matrix of lucent granules; the cell membrane 
(arrow)  was unlabeled. C and D were stained for LNR/fp9 (GS) and lactoferrin (G10).  LNR and lactoferrin antigens were co-localized 
in lucent granules (C and arrowheads in D) while the the dense granules were unlabeled (D, arrow). E and F were labeled with antibodies 
to LNR (GS) and elastase (G10).  Dense granules were positive for elastase (E and arrow in F) whereas specific granules were stained 
for LNR/fp9 (F,, arrowhead).  Bars: (A-C, E, and F) 200 urn;  (D)  100 urn. 
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Stimulation with Various Agonists* 
Stimuli  Myeloperoxidase¢  B~2-bindingi  LDHll 
%  %  % 
50 ng/ml PMA  1.6  4.8  0.05 
500 ng/ml PMA  6.2  24.7  0.13 
1 pM FMLP  2.3  9.8  0.12 
5 ~g/ml cytochalasin  D 
and  l  /~M fMLP  60.5  38.4  0.10 
DMSO control  2.8  2.8  0.13 
10 nM rTNFct  1.3  16.6  0.14 
Laminin  substrate  and 
10 nM rTNFc~  2.6  43.8  0.19 
Laminin  substrate  and 
buffer  2.4  5.2  0.09 
* Human PMNs intended for IEM were isolated from peripheral blood on 
FicolI-Hypaque  gradients and resuspended in HBSS containing 20 mM Hepes 
(pH 7.4) and 0.1% human serum albumin. Suspensions of 2 x  106 cells/ml 
were activated with the indicated agonists for 20 min at 37°C with continuous 
agitation (except for treatment with TNF which was for I h). APoer  activation, 
the PMNs were pelleted for fixation, and enzyme  activities  were assayed in the 
supernatants. PMNs (107) adherent to LN-coated 10-cm-diam  culture dishes 
were also treated with TNF for I h, and marker enzymes were measured in 
the culture media. 
¢ Myeloperoxidase  activity was measured to evaluate release of azurophilic 
granules. Equivalent PMN suspensions were also lysed with 0.5% NP-40 to 
determine the total amount of endogenous myeloperoxidase. 
§ Soluble vitamin B~2 binding activity was measured to quantify liberation of 
specific granules. 
I{ Lactate dehydrogenase release was used to quantify PMN lysis. 
detected within glycocalyx material closely associated with 
microvilli of activated PMNs  (Fig.  4  D, arrow). In double 
labeling experiments, both 67-kD LNR and CDI8 antigens 
were co-expressed as mixtures on the cell surface adjacent 
to specific granules fusing with the plasmalemma (Fig. 4 E), 
and also as isolated clusters elsewhere along the cell mem- 
brane (Fig. 4 F). Activated PMNs did not exhibit liberation 
of all Of their specific granules  (Fig.  4, A,  C, E). 
Binding of LN to Stimulated PMNs 
To assess  the  relevance  of LN binding  to  PMN  function, 
adhesion of PMNs to LN-coated substrata was measured in 
relation  to  cellular  activation.  Stimulation  with  fMLP  or 
PMA  resulted  in  increased  PMN  attachment  to  surface- 
bound  LN  in  a  dose-response  manner,  while  unactivated 
cells did not adhere well (Fig. 5). A  soluble LN-binding as- 
say was also established to further quantify the association 
of LN with  the  PMN  surface.  PMNs  activated  with  cyto- 
chalasin DIfMLP exhibited an 8.5-fold increase in specific 
binding  of soluble  LN  relative  to unstimulated  cells,  and 
PMA treatment increased this binding 6.6 times (Table II). 
Inclusion of 67-kD LNR/fp9 antibodies in the binding buffer 
caused a 4.2-fold reduction of specific LN binding compared 
to nonimmune  serum,  thus  supporting  the  functional  spe- 
cificity of the LNR/fp9 antibodies. 
Liberation  of Specific Granule Components from 
Activated PMNs 
Since 67-kD LNR and lactoferrin antigens were co-localized 
in specific granules, we asked whether PMN stimulation in- 
duced release of one or both of these components into the 
culture medium.  Cells were activated with cytochalasin D~ 
fMLP or PMA, and the release of 67-kD LNR and lactofer- 
rin was monitored with immunoblotting and densitometry of 
clarified culture supernatants (Table liD. Significant amounts 
of lactoferrin appeared in the media after activation with ei- 
ther agonist,  while 67-kD LNR was not released. 
Distribution of  LNR in Human Monocytes 
Resting human monocytes isolated from peripheral blood by 
elutriation contained electron lucent and dense cytoplasmic 
granules similar to those of PMNs (Fig. 6). As with the poly- 
morphonuclear granulocytes, monocytic lucent granules ex- 
hibited  intense  labeling  with  67-kD  LNR/fp9  antibodies, 
while the dense granules  and the cell membrane were un- 
stained (Fig. 6 A). Alternatively, both types of granules were 
positive for lysozyme epitopes (Fig.  6, B and D). In double 
staining experiments, both CD18 and lysozyme were co-dis- 
tributed with 67-kD LNR in monocytic lucent granules (Fig. 
6, C and D). The Golgi apparatus of these cells was unstained 
for LNR and CD18 antigens (Fig. 6 E). Upon activation with 
LPS, clusters of 67-kD LNR and CD18 epitopes were local- 
ized on the outer  surface of the plasmalemma. 
Detection of Other lntegrins in Lucent Granules 
of Leukocytes 
Since CDllb and CDI8 antigens were observed in PMN and 
monocyte lucent granules along with 67-kD LNR, we asked 
whether other integrin molecules were co-localized at these 
sites.  Using  antibodies  specific  for  the  alpha5  subunit  of 
mammalian  FNR,  or  for the  alphav chain  of VNR,  these 
additional receptors were located in lucent granules of PMNs 
(Fig. 7, A and D) and monocytes (not shown). In each case, 
the staining was eliminated by pretreatment of the antibodies 
with purified relevant receptor (Fig. 7, B and E), but not with 
irrelevant  integrins  (Fig.  7,  C  and F).  Double-staining  ex- 
periments  were  then  conducted  to determine  the  relation- 
ships between the distributions of 67-kD LNR, CD18, FNR 
and VNR antigens  in PMNs  and monocytes (Fig.  8).  Both 
FNR and VNR were colocalized with LNR (Fig.  8, A and 
Figure 4. Activation of human PMNs with 10 nM rTNF (,4 and C), 1.3 pM PMA (8 and D-F), or cytochalasin D plus fMLP (not shown; 
see Table I) causes expression of LNR/fp9 and CDI8 antigens on the cell surface. Cryosections of stimulated PMNs were stained with 
LNR/fp9 afffinity-purified IgG and pAG5 (A-D), or double labeled with antibodies recognizing LNR/fp9 and CDI8 antigens after protocol 
a described in Materials and Methods (E and F). (A) Stimulation-induced fusion of LNR containing specific granules (arrow) with the 
plasmalemma (arrowhead). (B) LNR-positive specific granule matrix (arrow) was sometimes found extending outward from the site of 
granule fusion with the cell membrane (arrowheads). Other activated PMNs exhibited uniform LNR/fp9 antigen labeling on the cell mem- 
brane (C and D, arrowheads), and LNR clusters on portions of the glycocalyx on microvilli (D, arrow). (E) Mixtures of LNR/fp9 (G5) 
and CDI8 ((310) antigens (arrowheads) were seen on the cell membrane adjacent to double-stained specific granules (arrow) apparently 
fusing with the plasmalemma. (F) Double-labeled clusters of LNR and CD18 antigens were also randomly distributed on the surfaces 
of activated PMNs. Bars:  (,4, E, and F)  100 nm; (B-D) 200 rim. 
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Figure 5. Adhesion of stimulated human PMNs to LN-coated sub- 
strata as a function of agonist dosage, PMNs were isolated from pe- 
ripheral blood on a Ficoll-Hypaque  gradient, activated with the in- 
dicated concentrations of agonists for 20 min at 37°C, and seeded 
(2  x  104 ceils per well) into Costar microtiter wells that were 
precoated with a  10-/~g/ml solution of LN purified from Engle- 
breth-Holm-Swarm sarcomas. After 1 h of incubation at 37°C, un- 
attached cells were washed away with a Cetus Pro/Pette, and the 
cells fixed with methanol and stained with hematoxylin.  Adherent 
PMNs were observed  with an inverted microscope at 195×, and 
the total number of attached cells per well was counted with an auto- 
mated image analyzer. Data shown represents the means of three 
determinations, and the bars are the standard errors. 
Table II. Specific Binding of  Soluble Laminin to Human 
PMNs Increases Due to Cellular Activation, and Is 
Inhibited by LNR/fp9 Antibodies* 
Experiment  Relative 
No.  Stimuli  LN bound,  cpm  change 
1  Unactivated  controls  357  - 
1  Cytochalisin D  +  fMLP§  3,041  +8.5 
2  Unactivated  controlll  1,500  - 
2  PMA  +  medium¶  9,900  +6.6 
2  PMA  +  nonimmune  serum**  14,000  +9.3 
2  PMA  +  anti-LNR/fpgs$  3,300  -4.2 
* Purified EHS sarcoma was iodinated  to a specific activity of 1.9 #Ci/#g (ex- 
periment No.  1) or 1.3 #Ci/#g (experiment No. 2) as described in Materials 
and Methods. 
S For experiment  No.  i,  1  x  106  human PMNs  were incubated  in  300 #1 
binding buffer containing 728 ng radiolabeled  LN +  100-fold  excess unlabeled 
LN for I h at 4"C. Unbound LN was separated from labeled PMNs by centrifu- 
gation at 900 g through a 0.5-M  sucrose cushion. The tubes were frozen on 
dry ice and the tips containing  the cell pellets were cut off and counted. Specific 
LN binding was determined  by subtracting the counts bound to PMNs incubat- 
ed with radiolabeled  LN plus unlabeled  ligand from those bound to cells treated 
with radioligand  alone. 
§ Cells were activated  with 5 #g/ml cytochalasin D and  1 #M fMLP for 20 
rain at 37"C before incubation  with LN. 
II In experiment  No.  2, 2.5  x  106  PMNs were incubated  with 670 ng  ~2sI- 
LN +  100-fold excess cold Iigand. 
¶ Stimulation  was performed  with 50 ng/ml PMA for 20 min at 37"C. 
** Nonimmune rabbit serum was added to the binding buffer at a final dilution 
of Ill(K). 
$$ The binding  medium was supplemented  with rabbit LNR/fp9 antiserum  at 
a final concentration  of 1/100. 
C), with CDI8 (Fig. 8, D  and E), and with each other (Fig. 
8 F) in the lucent granules of PMNs and monocytes (Fig. 8, 
G and H). Staining of integrins but not of 67-kD LNR anti- 
gens was eliminated by treating the primary antibodies with 
purified relevant integrin (Fig.  8 B). 
Discussion 
We have located antigens of 67-kD LNR, CDllb, CD18, and 
the alpha chains of FNR and VNR in the specific granules 
of human PMNs through the use of dual label IEM on ultra- 
thin frozen sections. PMN specific granules were identified 
by the presence of lactoferrin (a well-established marker of 
specific  granules),  the absence of elastase immunostaining 
(50),  and their electron lucent appearance.  Human mono- 
cytes exhibited similar granules that were positive for all four 
matrix receptors as well as lysozyme. Our observations are 
summarized in Table IV.  Since  67-kD  LNR definitely  co- 
distributed with lactoferrin, there can be little doubt that this 
receptor is packaged in specific granules as opposed to ter- 
tiary granules as suggested in subcellular fractionation stud- 
ies (78). After PMN activation (with PMA, fMLP, or gl'NF), 
or stimulation of monocytes using  LPS,  specific  granules 
Table IlL Densitometric Analysis of 67-kD LNR and 
Lactoferrin Released by Human PMNs after Activation* 
Density of  immunobloned protein 
relative  to control 
Stimuli  67-kD LNR  Lactoferrin 
Control  1.0  1.0 
Cytochalasin  D  and  1 #M fMLP  -36.0  +685.7 
500 ng/ml PMA  -4.0  + 133.3 
* PMNs were isolated  from  human peripheral  blood,  suspended  at  107 cells/ 
ml in MEM containing 5%  sucrose,  5 #g/ml N-methoxysuecinyl-ala-ala-pro- 
val chloromethyl ketone (an inhibitor  of PMN elastase), 20 mM Hepes (pH 
7.2),  and activated  as described in Table II. After activation,  the cells were 
centrifuged  at  10,000 g  and the supernatants  collected and concentrated  10- 
fold.  Aliquots of media were electrophoresed on SDS-PAGE gels, immuno- 
blotted  with  LNR/fp9  or lactoferrin  antibodies,  stained  with  radioiodinated 
protein  A, and autoradiographed  as described in Fig.  1. For each sample, the 
staining  density at 67 kD (LNR) or 77 kD (lactoferrin) was measured  with an 
LKB laser densitometer  fitted  with an analytical  integration  system, and ex~ 
pressed as a percentage  of the corresponding control  band. 
were observed fusing with the plasmalemma and both LNR 
and CD18 antigens were detected at the cell surface. These 
receptor antigens were co-localized as clusters within the 
glycoealyx, and they were also broadly distributed over the 
Figure 6. IEM distribution of LNR/fpg,  lysozyme, and CD18 antigens in resting (A-E) or activated (F and G) human monocytes. (,4) 
LNR/fp9 antigens (pAG5) were localized to lucent granules (arrow) similar to those seen in PMNs, but not on the cell membrane (arrow- 
head) or in dense granules (d). (B) Both dense (arrow) and lucent (arrowhead) granules were stained for lysozyme antigens (sarG10). 
(C) LNR/fp9 (G5) and CD18 (G10) antigens were co-distributed in lucent granules of double labeled monocytes stained using protocol 
b described in Materials and Methods. Dense granules (d) were unlabeled. (D) Lucent granules showed a similar co-localization  of LNR/fp9 
(G5) and lysozyme IgG ((310) in lucent granules, but dense granules (d) were only positive for lysozyme. (E) Monoeyte labeled with re- 
agents used in C; while a lucent granule was positive for LNR and CD18 (arrowhead), the Golgi apparatus (g) was unstained. Clusters 
of LNR/fp9 (F, arrowheads) and CD18 (G, arrowhead) antigens were observed on the outer cell surface after 20 h of LPS stimulation. 
Bars: (A, C, D, F, and B)  100 nm; (B and E) 200 nm. 
The Journal of Cell Biology,  Volume  109, 1989  3176 Singer et al. PMN and Monocyte Specific Granules Containing ECM Receptors  3177 Figure Z Alpha subunits of mammalian fibronectin receptor (FNR) and vitronectin receptor (VNR) were localized in the specific granules 
of resting human PMNs frozen with liquid propane. (A) Section stained with rabbit IgG specific for FNR alpha5 chain and then pAG5. 
(B) Incubation of FNR IgG with purified FNR prevented immunostaining of specific granules, while treatment with VNR did not inhibit 
FNR labeling (C). (D) Labeling with VNR alpha chain IgG was similarly restricted to specific granules, and inhibited by pretreatment 
with purified VNR (E) but notwith FNR (F). Bars: (A, C, D, and F) 100 nm; (B and E) 200 run. 
remainder of the cell surface.  Concomitant with this  sur- 
face expression of LNR and CDI8 epitopes, we observed in- 
creased binding of soluble LN and enhanced cellular adhe- 
sion to LN substrata in activated PMNs. These events were 
accompanied by liberation of myeloperoxidase, vitamin B,2 
binding protein, and lactoferrin, but not LNR antigens into 
the culture medium. Since four types of adhesion-promoting 
extracellular matrix receptors were co-expressed in leuko- 
cyte specific granules,  we propose that these granules be 
termed adhesomes. 
Several novel approaches were taken in the preparation of 
human leukocytes for high resolution IEM study. Since these 
cells contain  numerous proteolytic enzymes, fixation was 
performed with a mixture of protease inhibitors. In addition, 
The Journal of Cell Biology, Volume  109, 1989  3178 Figure 8. Double IEM labeling of unactivated human PMN specific granules (A-F) or monocyte lucent granules (G and H) for 67-kD 
LNR/fp9 or CDIS, and FNR alphas or VNR alpha-chains with a procedure similar to protocol b described in Materials and Methods; 
the cryogen was liquid propane. (A) PMN specific granule was positive for both LNR/fp9 ((35) and FNR alphas (G10) antigens; the dense 
(azurophilic) granule was unstained. (B) Incubation of FNR alphas antibodies with purified FNR prevented staining of specific granules 
with pAGI0, but did not block LNR/f-p9  labeling (pAG5). (C) VNR alpha-(G10) and LNR/fp9 (G5) antigens were co-localized in PMN- 
specific granules but not in azurophilic granules. CDI8 (G10) co-distributed with FNR alphas (G5) in D and VNR alpha-(G5) in E, and 
both FNR alphas (G10) and VNR alpha-(G5) also co-localized within PMN specific granules in E  (G) Monocyte lucent granule double 
labeled for FNR alphas (G10) and LNR/fp9 (G5) antigens. (H) VNR alpha-(G10) was also present along with LNR/fp9 (G5) in the mono- 
cyte lucent granule. Bars, 100 nm. 
cells were frozen by injection into liquid cryogen with an ap- 
paratus that insures very reliable cryopreservation (57). Fur- 
thermore, antibodies of well-defined specificity were used 
for extracellular matrix receptor (ECMR) localization in this 
study. 67-kD LNR was detected with affinity-purified rabbit 
IgG recognizing the COOH-termina1295 amino acids of hu- 
man LNR expressed in fp9, an E. coli fusion protein (37, 52, 
69). This antibody labels a single 67-kD species in immuno- 
blots of PMN or specific granule homogenates, and does not 
cross-react with human serum albumin. FNR and VNR were 
stained with rabbit antibodies that specifically recognize the 
alpha subunits of their respective receptors (56), and the im- 
munolabeling was  inhibitable by adsorption with purified 
relevant but not irrelevant receptor. CD18 localization was 
performed with monoclonal antibody 60.3 that recognizes 
the common beta subunit of the leukocyte adhesion complex 
(5, 51) and blocks PMN attachment to endothelial cell mono- 
layers in vitro and diapedesis in vivo (22, 72). Therefore, the 
IEM data reported here are very reliable. 
The lack of 67-kD LNR or CD18 IEM labeling on the sur- 
faces of resting PMNs and monocytes was somewhat unex- 
pected because recent immunofluorescent microscopic ex- 
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Leukocyte  Granules 
Cell  Specific granules  Azurophilic granules 
PMN  LNR (67 kD)  Elastase 
anti-whole 
anti-peptide 
CDIlb, CD18  None 
FNR~  None 
VNI~  None 
Lactoferrin  None 
Monocyte  LNR (67 kD)  None 
CD 18  None 
FNP~  None 
VNR~  None 
Lysozyme  Lysozyme 
periments have localized LNR/fp9 antigens on the surfaces 
of unstimulated  thioglycollate elicited  murine  peritoneal 
macrophages (37) and CD18 epitopes on the plasma mem- 
branes of resting human PMNs (38). Because antigens of ex- 
tracellular matrix receptors are known to be inactivated by 
glutaraldehyde (17), this discrepancy may be explained by the 
fact that  our  leukocytes were  fixed  with  glutaraldehyde, 
while those of the latter studies were treated with formalde- 
hyde or unfixed. We have in fact detected sparse LNR and 
CDI8  immunostaining on the  cell membranes of resting 
PMNs fixed with formaldehyde alone, and moderate levels 
of 67-kD  LNR and CD18  labeling were observed on the 
plasma membranes of activated PMNs and monocytes pre- 
served with glutaraldehyde. Previous IEM studies of the in- 
tracellular distribution of integrins using a polyclonal antise- 
rum recognizing CD1 lc (alpha subunit of p150,95) and CD18 
antigens on frozen sections of human leukocytes showed that 
their epitopes were localized in peroxidase negative vacuoles 
of monocytes (38), and along the membranes of PMN spe- 
cific granules (4). We likewise observed ECMR antigens on 
the membranes of these granules (Figs.  2 B and 3 B), but 
also detected ECMR within their electron lucent matrix. 
This difference may be attributed to improved ultrastructural 
preservation.  Because FNR, VNR,  CDIlb,  and CD18  are 
transmembrane proteins and 67-kD LNR has the properties 
of a tightly bound peripheral membrane protein (52), it was 
surprising to find their epitopes distributed in the granule 
matrix and upon its inner membrane surface. Several expla- 
nations may account for the location of ECMRs within the 
adhesome matrix. Given recent EM observations of highly 
purified human FNR which show that the combined length 
of its "head" and "tails" is approximately fivefold greater than 
the thickness of a membrane (41), we estimate that ~2/3 of 
the adhesome matrix might be occupied by extended integrin 
molecules presenting antigens for immunolabeling. Thus, 
tangential sectioning of obliquely oriented adhesome mem- 
branes could be responsible for the centralized appearance 
of ECMRs in these granules. Previous IEM studies of secre- 
tory vesicles have also documented a  central location for 
other integral membrane proteins such as vesicular stomati- 
tis virus membrane glycoprotein G  and epidermal growth 
factor receptor (7,  11). Further, we have recently localized 
antibodies against the intracytoplasmic domain of CDllb to 
the outer membrane surfaces of PMN adhesomes in the ab- 
sence of internal labeling (Singer, I. I., and S. D. Wright, un- 
published observations).  Together,  these staining patterns 
document the expected transmembrane orientation of the ex- 
traceUular and cytoplasmic domains of the integrin Mac-1. 
Despite the presence of 67-kD LNR antigens within the ad- 
hesome matrix, we have not been able to detect a substantial 
release of LNR into the culture medium concurrent with 
abundant lactoferrin secretion after PMN activation. These 
results strongly suggest that ECMRs present in the adhesome 
are tightly bound to its membranes after fusion with the cell 
surface. 
Fusion of specific granules containing several  ECMRs 
with the leukocyte plasmalemrna after activation suggests 
that ECMR up-regulation may be responsible for increases 
in ligand binding and cellular adhesion observed after treat- 
ment with agonists. This suggestion is supported by a large 
number of studies documenting increased surface expression 
of leukocyte integrins and LNR in activated PMNs, mono- 
cytes, and platelets (6,  33,  38,  62,  64,  67, 68).  However, 
ECMR up-regulation probably does not by itself fully ac- 
count for the effects of agonists on the adhesive behavior of 
leukocytes. For example, in time course experiments of acti- 
vated human PMNs, the kinetics of CD18 up-regulation do 
not coincide precisely with increases in cellular adhesion 
(33, 44, 64, 71). Also, PMN aggregation and attachment to 
endothelial cell monolayers have been dissociated from in- 
creased surface expression of CD1 lb/CD18 complex (16, 44, 
65).  IEM of CDllb distribution on PMNs has shown that 
stimulation with PMA induces formation of CD1 lb clusters, 
and that the time-course of this receptor aggregation is coin- 
cident with enhanced binding of complement-coated erythro- 
cytes; receptor disaggregation also correlated with decreased 
ligand binding at later times (18). Similarly, PMA treatment 
of murine macrophages induced cell attachment to LN-coat- 
ed substrata and clustering of surface 67-kD  LNR detected 
using immunofluorescent  microscopy with the LNR antibod- 
ies of  the present study (37). Likewise, we have demonstrated 
that stimulation of  human PMNs with either PMA, rTNF, or 
fMLP, or monocytes with LPS, leads to fusion of adhesomes 
with the plasmalemma concomitant with increased surface 
expression of ECMR aggregates consisting of co-clustered 
LNR and CDI8 antigens. These results suggest that aggrega- 
tion also plays a role in the enhancement of ECMR function 
and regulation of cellular adhesion in activated leukocytes. 
Other alterations such as ECMR phosphorylation, confor- 
mational changes, or interaction with the cytoskeleton or 
other  surface membrane components might also  regulate 
ECMR function (15, 37, 64, 72). 
Packaging of 67-kD LNR, CDllb, CDI8, FNR, and VNR 
within specific granules,  and co-distribution of LNR and 
CD18 in clusters on the surfaces of activated cells may help 
to explain how the extracellular matrix regulates some as- 
pects of leukocyte function. First, attachment of macrophages 
to  surfaces coated with FN  or  LN activates their Mac-1 
receptors which then engage in increased phagocytosis of 
C3bi-coated particles (10, 45,  71). This effect is reversible 
and also dependent upon the interaction of substrate-bound 
FN with FNR since it is blocked by RGD peptides (73, 74). 
Because FNR and CD18 are co-distributed in adhesomes, we 
suggest that FNR might also be located in close proximity 
to CD18  in ECMR clusters seen on the cell membranes of 
activated monocytes. We speculate that cross-linking of FNRs 
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conformational  changes  in  neighboring  Mac-I  receptors 
leading to their activation. Second, inflammatory agonists 
such as fMLP or TNF induce maximal respiratory burst and 
H202 production in PMNs only when the cells are spread 
upon extracellular matrix-coated substrata,  or endothelial 
cell monolayers; the process requires microfilament assem- 
bly during stimulation (39).  This effect is accompanied by 
the release of  the specific granule components lactoferrin and 
vitamin B~2 binding protein into the medium,  while con- 
tents of azurophilic granules are not secreted (34).  Further, 
CD18 antibodies that block attachment of PMNs to C3bi or 
fibrinogen also  inhibit TNF-induced respiratory burst  on 
surfaces coated with LN,  fibrinogen, or thrombospondin 
(40). Perhaps the close spatial association of CD18 and LNR 
on the surface of the activated PMN provides an explanation 
for this phenomenon. In addition, since b-cytochrome, an 
electron transporter involved in generating the PMN respira- 
tory burst (19), is localized with ECMRs in specific granules 
(adhesomes) and translocated to the plasma membrane after 
PMN activation (12), we hypothesize that this up-regulation 
may be ECMR-driven. As FNR and VNR link the extracellu- 
lar matrix  to  the  actin cytoskeleton at  cell-to-substratum 
adhesion sites  (53,  54,  56),  perhaps  patching and cross- 
linking of LNR, FNR, or Mac-1 receptors by their immobi- 
lized ligands induces polymerization of actin microfilaments 
(via phosphorylation), and this network translocates specific 
granules/adhesomes to the cell surface. Whatever the mecha- 
nism, the adhesome undoubtedly serves as a secretory unit 
that commandeers several ECMRs to the PMN surface sim- 
ultaneously. In this manner, the coordinated expression of 
ECMRs that facilitate cellular adhesion to the endothelial 
surface (Mac-l), basement membranes (LNR), and the sur- 
rounding connective tissue stroma (FNR, VNR) is ensured 
during extravasation of PMNs and monocytes in response to 
chemotaxins and inflammatory stimuli. 
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